

Other version: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905310/
![]() |
Case Report: Severe Complement-Mediated Thrombotic Microangiopathy in IgG4-Related Disease Secondary to Anti-Factor H IgG4 Autoantibodies |
|
Authors | ||
Published in | Frontiers in immunology. 2021, vol. 11, 604759 | |
Abstract | Objective: To first describe and estimate the potential pathogenic role of Ig4 autoantibodies in complement-mediated thrombotic microangiopathy (TMA) in a patient with IgG4-related disease (IgG4-RD). Methods: This study is a case report presenting a retrospective review of the patient's medical chart. Plasma complement C3 and C4 levels, immunoglobulin isotypes and subclasses were determined by nephelometry, the complement pathways' activity (CH50, AP50, MBL) using WIESLAB® Complement System assays. Human complement factor H levels, anti-complement factor H auto-antibodies were analyzed by ELISA, using HRP-labeled secondary antibodies specific for human IgG, IgG4, and IgA, respectively. Genetic analyses were performed by exome sequencing of 14 gens implicated in complement disorders, as well as multiplex ligation-dependent probe amplification looking specifically for CFH, CFHR1-2-3, and 5. | |
Keywords | IgG4-related disease — SARS CoV2 — Anti-factor H auto-antibodies — Antibodies — Atypical hemolytic uremic syndrome — Complement factor H — Complement factor H-related protein — Thrombotic microangiopathy | |
Identifiers | PMID: 33643292 | |
Full text |
![]() ![]() Other version: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905310/ |
|
Structures | ||
Research group | Laboratoire d'immunologie translationnelle (856) | |
Citation (ISO format) | BREVILLE, Gautier et al. Case Report: Severe Complement-Mediated Thrombotic Microangiopathy in IgG4-Related Disease Secondary to Anti-Factor H IgG4 Autoantibodies. In: Frontiers in Immunology, 2021, vol. 11, p. 604759. doi: 10.3389/fimmu.2020.604759 https://archive-ouverte.unige.ch/unige:155532 |